MENU
 

PRE TAX NTA |$3.76

Value as at close of business on 17 January 2024

Sohn Hearts & Minds Investments fund targets $1.5bn valuation

Chris Cuffe, chairman of Hearts and Minds Investments, with chief investment officer Charlie Lanchester. Picture: John Feder

‍Hearts & Minds Investments chair Chris Cuffe is hoping for the six-year-old fund, which gives 1.5 per cent of its assets to medical research charities each year, to grow to more than $1.5bn in the next five years.


In an interview with The Australian ahead of Friday’s Sohn conference in Adelaide, the veteran fund manager and philanthropist says he sees his role as growing the assets of the fund, now at $800m, after raising an initial $500m when it was listed on the ASX in November 2018.


The HM1 fund is an extension of the original Sohn Australia Hearts & Minds organisation, which runs an annual conference where attendees pay some $3500 to hear some of the world’s top fund managers tip stocks, with proceeds going to medical research charities. This year HM1 will give $12m to research charities in addition to the money raised by the conference.


“I view my role here as trying to grow this fund to be as large as possible, hopefully through good performance which we have seen recently,” says Cuffe. “The bigger the fund, the more we give away.”


HM1 is a unique high conviction global equity fund which holds 31 stocks.


It invests 35 per cent of its assets in the 10 stocks recommended by Sohn conference fund managers each year, which it holds for a maximum of 12 months, and the other 65 per cent in what it calls its core portfolio, chosen by seven selected fund managers who each pick three of their best stocks, and these can be held for a much longer duration.


HM1 was set up two years after the Australian version of the New York-based Sohn conference was launched in November 2016, as local organisers saw it as a way to turbocharge the money raised by the conference and its concept of raising funds for medical research, which originated in New York in the 1980s.


The Australian organisers decided to set up a listed investment company which would invest in the stocks tipped by the fund managers. The company now owns the Sohn Australia Hearts & Minds conference.


While the annual conference is the core to the Sohn concept, Cuffe says HM1 has become “the goliath in the room” when it comes to raising money, giving much more to the medical research charities from the fund.


“The conference was the original money making thing,” Cuffe recalls.


“We thought we could dial it up if we got a decent sized listed investment company to make it easier for people to buy the stocks picked by the Sohn conference fund managers.”


So far, the Sohn Australia conference organisation has donated $70m to medical research – with $54m coming from HM1 and $16m from the Sohn Hearts & Minds conferences over the years.


HM1 is now one of Australia’s top 30 corporate philanthropists.


The top 10 holdings in the fund’s long term core portfolio are Amazon, Block, Microsoft, Taiwan semiconductor giant TSMC, Guzman Y Gomez, Mastercard, Intercontinental Exchange, Formula One Group, and Opthea.


But it has not been plain sailing. After listing in November 2018, HM1’s share price rose to around $4.78 in early 2021.


But its shares, with a heavy exposure to global and tech stocks, were hit by the fall in markets during Covid which saw its profits fall and its share price slide to a low of $2.08 in mid-2022.


It recovered from $2.47 in January this year, but HM1 is still only trading at around $3.06.


The fall in earnings and share price prompted Cuffe and the HM1 team to revise their strategy, taking a much more active approach to managing the portfolio.


A key player in the turnaround has been chief investment officer Charlie Lanchester, a fund manager with 30 years experience, who stepped into the role in April last year after eight years with Blackrock.


His role includes actively watching the performance of stocks tipped at the conference and being prepared to take profits or sell out earlier than the 12 month holding period, including being prepared to take a loss if it looks like the scenario outlined by the fund manager who tipped the stock takes longer to play out than the 12 month holding period.


Lanchester also plays a role in selecting fund managers who present at the conference, liaising with them to make sure that there is a diversification in the stocks tipped at the conference, such as not having too much exposure to technology stocks. “Making sure we’ve got the best possible managers in the core portfolio is part of my job, as well as being part of the selection process for which fund managers present at the conference,” he says.


When managers of the core portfolio recommend a stock to buy, Lanchester challenges them, making sure they are looking ahead to how the stock could perform in the future, and are not just recommending one which has performed well in the past. Fund managers, he says, are often reluctant to sell favourite stocks.


Last year it also appointed two new core fund managers, Munro Partners and Tribeca Investment Partners. While most of the fund’s stocks are listed, it is allowed to own some private companies.


HM1 invested in Guzman y Gomez in January 2023, prior to its initial public offering, through its core portfolio, at a price equivalent to $16 per share.


The stock was subsequently tipped at the conference last November. The stock has since listed, providing HM1 with a return of 150 per cent. Other stocks which have done well for HM1 in the past have included some in last year’s stock picks including Telix Pharmaceuticals which was up 125 per cent in 12 months. It was tipped by IFM’s Ricki Bannan. Bed and Bath Works, tipped by Dan Loeb at Third Point, gained 55 per cent in two months. Unicredit rallied 38 per cent and was tipped by Martin Hughes from the Tosca Fund, while Ellerston’s Chris Kourtis tipped ResMed which rose 26 per cent.


The changes have seen an improvement in the fund’s performance with its portfolio up 32 per cent for the 12 months to October 31 this year. Despite the difficult time of 2021 and 2022, it has delivered an annualised pre-tax investment return of 10.7 per cent a year since inception.


Its share price is trading at a 12 per cent discount to portfolio market value, an improvement from the earlier 20 per cent. The fund has also paid fully franked dividends totalling 53c per share, or a fully franked dividend yield of 5.3 per cent a year.


While HM1 now gives the bulk of the money to the research charities, the conference still plays a key role in the Sohn concept. “The conference adds a little bit more to (the funds donated by HM1), but it is much smaller,” says Cuffe. “The listed investment company is the big give away.


“But the conference has a key role showcasing the medical research charities as well as the fund managers and their stock picks.


Cuffe says other Sohn conference organisations around the world “look at us with envy because the philanthropic model has been so much more effective. We have given way more money than would have been raised by just having the conference.”


The 10 stocks which will be pitched at the conference on Friday will go into the fund after they are announced. “We have sold out of last year’s stocks, and we are ready for the new stocks to come in,” Cuffe says.


This year’s Sohn Hearts & Minds will be hosted in Adelaide at the Festival Theatre. Themes include space, AI, geopolitics, biosciences and investing. It is being held in partnership with the South Australian government.


This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on 14 November 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Recent Posts

Read the latest insights
A curated list of HM1 investor updates, portfolio news and other interesting articles.
Read More
Nine top stock picks to prepare your portfolio for 2025
Health care, ride-sharing, and the emerging world of YouTube entertainers are among the industries leading investors have picked for growth in 2025.
Resources fundies reveal top picks ahead of ‘stellar’ 2025
Some of Australia’s biggest resources funds are gearing up for a bumper start to the new year.
Qiao Ma: finding killer companies, surviving the GFC & why founders win
Qiao Ma, Portfolio Manager of the Munro Partners joins Owen Rask on The Australian Investors Podcast.
10 top fund managers reveal their long-term stock picks
With valuations stretched and geopolitical tensions high, the new year offers plenty of potholes for investors. 
 

Nine top stock picks to prepare your portfolio for 2025

Health care, ride-sharing, and the emerging world of YouTube entertainers are among the industries leading investors have picked for growth in 2025.

Read More
January 21st, 2025
 

Resources fundies reveal top picks ahead of ‘stellar’ 2025

Some of Australia’s biggest resources funds are gearing up for a bumper start to the new year.

Read More
January 6th, 2025
 

Qiao Ma: finding killer companies, surviving the GFC & why founders win

Qiao Ma, Portfolio Manager of the Munro Partners joins Owen Rask on The Australian Investors Podcast.

Read More
January 6th, 2025
 

10 top fund managers reveal their long-term stock picks

With valuations stretched and geopolitical tensions high, the new year offers plenty of potholes for investors. 

Read More
December 28th, 2024
 

Rikki Bannan – Don’t get caught up in momentum

Conference Fund Manager Rikki Bannan, Executive Director at IFM Investors, joins Equity Mates to discuss her standout 2023 stock pick, Telix, and explore what opportunities lie ahead.

Read More
December 19th, 2024
 

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
December 10th, 2024
 

Nick Griffin – The Nvidia story is not over

Nick Griffin, Founding Partner & Chief Investment Officer of Munro Partners joined the Equity Mates podcast in their Summer Series.

Read More
December 9th, 2024
 

HM1 CEO Succession

Hearts and Minds Investments Limited advises that Paul Rayson intends to retire from the position of Chief Executive Officer, effective 19 February 2025.

Read More
December 5th, 2024
 

Trump unifies top investors in decade-long bullish outlook for US

Nick Moakes, CIO of the $72 billion Wellcome Trust, told the conference that too many investors were banking on a return to the ultra-low interest rates that prevailed over the past decade.

Read More
November 20th, 2024
 

These rock-star stock picks could get markets talking next year

Eleven rock stars of international and local funds management took to stage – each tasked with picking and pitching one company whose shares will take off over the next year.

Read More
November 18th, 2024
 

Is anyone brave or stupid enough to bet against America?

Stock pickers have been punished for betting against the US. The choice between consensus and contrarianism on American exceptionalism is now harder than ever.

Read More
November 17th, 2024
 

Sohn: NYSE-listed Estee Lauder’s Northcape Capital pick

Northcape Capital’s Fleur Wright this gives a rare opportunity to buy a high quality company at an attractive price.

Read More
November 15th, 2024
 

Sohn ASX stock pick: Ellerston Capital’s Chris Kourtis backs Perpetual

Chris Kourtis has put his biggest bet on embattled Perpetual – picking one of the most hated stocks on the ASX – that he believes will soon be the ‘cheapest listed asset manager of scale in the universe’.

Read More
November 15th, 2024
 

AI start-ups a threat to incumbent big companies

Paul Bassat predicts emerging artificial intelligence companies will disrupt sectors and overtake established incumbent companies just as rapidly as the seismic shifts that took place when the internet emerged in the mid-1990s.

Read More
November 15th, 2024
 

Howard Marks and Sohn’s big stars reveal seven rules for investing

Among the stock picks and stunts at the Sohh Hearts & Minds event, Howard Marks and Nick Moakes provided investors with long-term rules for playing markets.

Read More
November 15th, 2024
 

Sohn investors position for bullish but bumpy Trump ride

Australia and the rest of the world must adjust to a new Trump presidency that will deliver an expected bull market but also disruption, with the leader in waiting prepared to “create pain” to get his way.

Read More
November 15th, 2024
 

Sohn stock picker experts name best shares to invest in for year ahead

‍Don’t overlook down and out silver miners, legacy skincare brands ready for a revival and a big financial company suffering from a severe case of shareholder wealth destruction.

Read More
November 15th, 2024
 

Eleven stock tips from Sohn to get you through 2025

“There’s no finer place for the finance festival than in the festival city,” said Matthew Grounds. He, along with fellow Barrenjoey co-executive chairman Guy Fowler and investor Gary Weiss, is one of Sohn’s driving forces.

Read More
November 15th, 2024
 

Sohn Hearts & Minds Investments fund targets $1.5bn valuation

‍Hearts & Minds Investments chair Chris Cuffe is hoping for HM1 to grow to more than $1.5bn in the next five years.

Read More
November 14th, 2024
 

Galaxy Digital CEO Mike Novogratz believes bitcoin will hit $US100k

Bitcoin’s bounce to record highs in recent days is only the beginning of a fresh surge higher for cryptocurrency, says US billionaire Mike Novogratz.

Read More
November 9th, 2024
 

Why this New York hedge fund manager sees opportunity in European stocks

Influential New York-hedge fund manager Ricky Sandler will turn to Europe for his next stock pick.

Read More
November 6th, 2024
 

Antipodes’ Ross says short-term wealth hinges on US election

The portfolio manager says defensive stocks pose a bigger risk than the magnificent seven for investors that are overexposed to the American sharemarket.

Read More
November 5th, 2024
 

Concentration risk key for investors: Antipodes Partners’ Vihari Ross

The concentration risk in global stock indexes that has built up during the strong rise over the past year must now be a key consideration for global investors, according to Vihari Ross.

Read More
November 5th, 2024
 

The fundie betting big on China – with help from AI

Mr Mehta is sticking to his well-worn strategy: he’s hunting for companies across Asia that aren’t battling intense competition and have management teams focused on costs, cash generation and high payouts to shareholders.

Read More
November 5th, 2024
 

Why this fundie wants you to ‘wince’ at his stock picks

When fund managers come to pitch their favourite stock at the annual Sohn Hearts & Minds conference, there are two ways they can go: they can play it safe, or they can take a risk and shock the room.

 

Read More
October 29th, 2024
 

IFM Investors’ Rikki Bannan backs small cap investments to rebound after mixed performance

IFM Investors executive director Rikki Bannan believes this year could be a good one to invest in some select small cap stocks.

Read More
October 27th, 2024
 

Meet the 2024 Conference Managers

Following a global search, the Conference Fund Manager Selection Committee is pleased to share eleven new managers for 2024. 

Read More
October 22nd, 2024
 

Chris Kourtis is on a winning streak. Here’s his next ASX pick

Chris Kourtis of Ellerston Capital thinks he’s found another winner and thinks it’s the last chance to have a bite at the cherry before the strategy plays out.

Read More
October 21st, 2024
 

Why Ellerston Capital’s Chris Kourtis plans to back a ‘hated’ stock

Chris Kourtis of Ellerston Capital plans to tip one of the “most hated” stocks in Australia when he presents at the 2024 Sohn Hearts & Minds Conference.

Read More
October 21st, 2024
 

Alex Pollak champions rewards of disruptive investment

Alex Pollak’s funds management company Loftus Peak rode the Nvidia wave and he is now looking at more opportunities in disruptive industry stocks.

Read More
October 14th, 2024